In the News May 28, 2019

The Deal | OncoSec Raises Capital to Fuel Clinical Trials

Alston & Bird is noted for representing OncoSec Medical Inc. in its $11 million initial public offering.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement